Compounds > colforsin
Page last updated: 2024-08-23

colforsin and imatinib mesylate

colforsin has been researched along with imatinib mesylate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Blaser, BW; Bloomfield, CD; Bruner-Klisovic, R; Caligiuri, MA; Chang, JS; Galietta, A; Liu, S; Mao, H; Marcucci, G; Neviani, P; Notari, M; Perrotti, D; Roy, DC; Santhanam, R; Trotta, R; Uttam, A; Valtieri, M1
Kirken, RA; Oaxaca, DM; Rodriguez, G; Ross, JA; Staniswalis, JG; Yang-Reid, SA1
Doi, Y; Hiyama, G; Ishikawa, K; Kasahara, Y; Nakamichi, K; Semba, K; Takagi, M; Tamamura, S; Watanabe, S1

Other Studies

3 other study(ies) available for colforsin and imatinib mesylate

ArticleYear
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.
    Cancer cell, 2005, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Benzamides; Blast Crisis; Cell Line, Transformed; Chromosomal Proteins, Non-Histone; Colforsin; DNA-Binding Proteins; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Histone Chaperones; Humans; Imatinib Mesylate; In Vitro Techniques; K562 Cells; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, SCID; Neoplasm Transplantation; Phosphoprotein Phosphatases; Piperazines; Protein Phosphatase 2; Pyrimidines; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins

2005
Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:9

    Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Colforsin; Drug Resistance, Neoplasm; Drug Synergism; Fusion Proteins, bcr-abl; HEK293 Cells; Hep G2 Cells; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Protein Kinase Inhibitors; Pyridazines; src-Family Kinases

2016
Tyrosine Kinase Inhibitor Profiling Using Multiple Forskolin-Responsive Reporter Cells.
    International journal of molecular sciences, 2023, Sep-08, Volume: 24, Issue:18

    Topics: Colforsin; Dasatinib; Humans; Imatinib Mesylate; Protein Kinase Inhibitors; Tyrosine Kinase Inhibitors

2023